Eid Ahmad M, Naseef Hani, Jaradat Nidal, Ghanim Lina, Moqadeh Roaa, Yaseen Miasar
Department of Pharmacy, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus P.O. Box 7, Palestine.
Pharmacy Department, Faculty of Pharmacy, Nursing and Health Professions, Birzeit University, Ramallah P.O. Box 14, Palestine.
Gels. 2023 Feb 27;9(3):186. doi: 10.3390/gels9030186.
The goal of this study was to make Benzoyl Peroxide (BPO) nanoemulgel to improve its ability to kill bacteria. BPO has trouble getting into the skin, being absorbed by the skin, staying stable, and being spread out.
A BPO nanoemulgel formulation was prepared by combining BPO nanoemulsion with Carbopol hydrogel. The drug was tested for solubility in various oils and surfactants in order to select the best oil and surfactant for the drug, and then the drug nanoemulsion formulation was prepared using a self-nano-emulsifying technique with Tween 80, Span 80, and lemongrass oil. The drug nanoemulgel was looked at in terms of its particle size, polydispersity index (PDI), rheological behavior, drug release, and antimicrobial activity.
Based on the solubility test results, lemongrass oil was the best solubilizing oil for drugs, while Tween 80 and Span 80 demonstrated the highest solubilizing ability for drugs among the surfactants. The optimum self-nano-emulsifying formulation had particle sizes of less than 200 nm and a PDI of close to zero. The results showed that incorporating the SNEDDS formulation of the drug with Carbopol at various concentrations did not cause a significant change in the particle size and PDI of the drug. The zeta potential results for drug nanoemulgel were negative, with more than 30 mV. All nanoemulgel formulations exhibited pseudo-plastic behavior, with 0.4% Carbopol exhibiting the highest release pattern. The drug nanoemulgel formulation worked better against bacteria and acne than the product on the market.
Nanoemulgel is a promising way to deliver BPO because it makes the drug more stable and increases its ability to kill bacteria.
本研究的目的是制备过氧化苯甲酰(BPO)纳米乳凝胶,以提高其杀菌能力。BPO在进入皮肤、被皮肤吸收、保持稳定以及扩散方面存在困难。
通过将BPO纳米乳液与卡波姆水凝胶混合制备BPO纳米乳凝胶制剂。对该药物在各种油和表面活性剂中的溶解度进行测试,以选择最适合该药物的油和表面活性剂,然后使用吐温80、司盘80和柠檬草油通过自纳米乳化技术制备药物纳米乳液制剂。从粒径、多分散指数(PDI)、流变行为、药物释放和抗菌活性等方面对药物纳米乳凝胶进行研究。
基于溶解度测试结果,柠檬草油是药物的最佳增溶油,而吐温80和司盘80在表面活性剂中对药物表现出最高的增溶能力。最佳的自纳米乳化制剂粒径小于200nm,PDI接近零。结果表明,将药物的自纳米乳化药物递送系统(SNEDDS)制剂与不同浓度的卡波姆混合,不会导致药物的粒径和PDI发生显著变化。药物纳米乳凝胶的zeta电位结果为负,大于30mV。所有纳米乳凝胶制剂均表现出假塑性行为,0.4%的卡波姆表现出最高的释放模式。该药物纳米乳凝胶制剂在对抗细菌和痤疮方面比市场上的产品效果更好。
纳米乳凝胶是一种有前景的BPO递送方式,因为它能使药物更稳定并增强其杀菌能力。